Callitas Health (MPHMF) Stock Price, News & Analysis

Company Overview

Callitas Health Inc. is a development-stage biotechnology company focused on creating pharmaceutical therapies for women’s health and related medical conditions. Its research activities have included potential treatments for female sexual dysfunction, sexual health, and other areas of unmet medical need.

The company has historically pursued product candidates through research, development, and clinical evaluation rather than operating as a diversified commercial pharmaceutical business. Available public information indicates that Callitas Health has focused primarily on advancing early-stage therapies and seeking opportunities to develop or commercialize specialized healthcare products.

Callitas Health was previously associated with M Pharmaceutical Inc. and has operated as a smaller, internationally oriented biotechnology business. Detailed, current information about its commercial products, geographic operations, and executive leadership is limited in publicly available sources.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 18,885 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/25/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Measuring & controlling devices, not elsewhere classified
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MPHMF
• CIK: N/A
• Web: www.callitas.com
• Phone: (859) 868-3131
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $530 thousand
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -3.50